Ads
related to: Severe Asthma- Specialty Pharmacy Finder
Search By State For Contact Info
For Community Specialty Pharmacies.
- Savings Program
Your Patients May Be Eligible For A
Savings Program, Learn More.
- Severe Asthma Biologic
Explore A Severe Asthma Treatment
Option That May Help Your Patients.
- Eosinophil Calculator
Convert Your Patient's Lab Results
& See How This Treatment May Help.
- Physician Resources
Access Helpful Physician Resources
And Downloadable Materials.
- Safety Information
Review Safety Profile Information
And Safety Extension Study Data.
- Specialty Pharmacy Finder
Search results
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga via Yahoo Finance· 1 day agoSunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 15 hours agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 16 hours agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
More Kids With Asthma Need Hospital Care on Very Hot Days
WFMZ Eastern Pennsylvania and Western New Jersey· 12 hours agoHeat waves and heat domes are particularly dangerous to kids with asthma, a new study finds. Daytime...
Are your seasonal allergies worse this year? Here's why—plus tips for symptom relief
CNBC· 3 days agoMore severe symptoms of seasonal allergies this spring are likely due to a warmer winter and an...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Morningstar· 15 hours agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both ...
GSK's SWIFT trial anthology shows long-acting treatment reduces asthma attacks
FierceBiotech· 16 hours agoCenter stage is depemokimab, a biologic GSK calls “ultra-long-acting” with a binding affinity and high potency for interleukin-5. IL-5 is a known key protein for asthma patients ...
Fibromyalgia, IBS patients linked to multiple-drug | Newswise
Newswise· 2 days agoMay 20, 2024 – Patients with fibromyalgia and irritable bowel syndrome (IBS) who take multiple...
Proteologix, Inc. to be Acquired by Johnson & Johnson
WFRV 5 Green Bay· 5 days agoProteologix's portfolio includes PX128, a bispecific antibody targeting IL-13 plus TSLP, which is ready to enter phase 1 development for moderate to severe atopic dermatitis ...
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga· 1 day agoSunday, Amgen Inc AMGN and AstraZeneca Plc AZN announced the results of the Phase 2a COURSE trial of...